-
Mildronate-Derived Lipidoids for Safer mRNA Vaccines
2026-09-12
A 2024 ACS Nano study developed mildronate-derived cationic lipids that enabled effective mRNA delivery at a low lipid dose while reducing local inflammation relative to an SM102-based comparator. In prophylactic and therapeutic B16OVA melanoma models, the resulting mLNP-69 formulation supported vaccine activity, providing a preclinical framework for balancing expression, immune activation, and tolerability.
-
Cy5 TSA Fluorescence System Kit for Tissue Repair Studies
2026-09-11
The Cy5 TSA Fluorescence System Kit helps resolve weak spatial signals in intestinal inflammation models, from CCDC25 and IL-22 immunostaining to transcript detection by FISH. Its HRP-dependent, covalent Cy5 deposition can improve sensitivity while conserving scarce antibodies and preserving tissue-level localization.
-
TAK-715: Practical p38 MAPK Inhibitor Workflows
2026-09-11
TAK-715 is a potent, p38α-focused research reagent for connecting kinase activity with cytokine output in cell-based inflammation models. Its nanomolar potency, distinct inhibitory profile, and suitability for mechanistic dephosphorylation assays make it useful for both routine pathway inhibition and advanced rheumatoid arthritis research.
-
2-Thio-dCTP Workflows for Precision DNA Studies
2026-09-10
2-Thio-dCTP enables controlled tests of DNA polymerase selectivity, site-specific DNA modification, and DNA–protein interactions rather than serving as a one-size-fits-all replacement for dCTP. This practical guide connects those established biochemical uses with the emerging SCP4–H3T3 chromosome-stability pathway while separating validated workflows from exploratory applications.
-
Candida krusei Phase-Specific Apoptosis in BMECs
2026-09-10
The reference study shows that Candida krusei yeast and hypha phases trigger bovine mammary epithelial-cell apoptosis through different signaling routes. Yeast cells preferentially engage mitochondrial injury, whereas hyphae more strongly involve death ligand/receptor signaling, with TLR2/ERK and JNK/ERK pathways contributing to both responses.
-
BIIE 0246: Mapping Y2R in Neurocardiac Models
2026-09-09
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating Y2R-dependent signaling from the Y1R mechanism implicated in adipose-neural cardiac arrhythmia. This article translates the key findings of Fan et al. into practical assay-selection, control, and interpretation strategies.
-
LL-37 Fragments Against MDR Acinetobacter Biofilms
2026-09-09
The reference study evaluates human cathelicidin LL-37 and three truncated fragments against multidrug-resistant Acinetobacter baumannii, combining planktonic killing, anti-adherence, biofilm inhibition, and biofilm dispersal assays. Its main contribution is showing that selected fragments, particularly KS-30 and KR-20, can retain clinically relevant antimicrobial activity while also targeting biofilm-associated phenotypes.
-
Nonivamide for TRPV1 and Cancer Research
2026-09-08
Nonivamide is a capsaicin analog that enables paired TRPV1 calcium-signaling and cancer cell growth inhibition studies. This guide translates receptor pharmacology, apoptosis assays, glioma research, small cell lung cancer models, and sensory-neuron findings into practical workflows with formulation and troubleshooting guidance.
-
Cy5 TSA Fluorescence System Kit Workflow
2026-09-08
The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright, far-red signal for difficult IHC, ICC, and FISH targets. This guide connects atlas-informed experimental design with practical deposition parameters, quantitative controls, and troubleshooting for reliable detection of low-abundance targets.
-
Stattic: A Causal Probe of STAT3 Across Cell Contexts
2026-09-07
STAT3 is a convergence point linking cellular stress, survival, vascular remodeling, and treatment resistance. This thought-leadership guide examines how Stattic can move translational research beyond pathway description by connecting STAT3 mechanism to experimental causality, HNSCC radiosensitization, apoptosis, and emerging lymphatic biology.
-
Human PSC Myogenic Progenitors for Durable Engraftment
2026-09-07
Khosrowpour et al. show that CD82+ ERBB3+ NGFR+ progenitors isolated from human PSC-derived teratomas can generate persistent human dystrophin-positive muscle and a dynamic PAX7-positive satellite cell pool in vivo. The longitudinal design, evidence of progressive fiber maturation, and retained activity after cryopreservation strengthen the case for teratoma-derived progenitors as a platform for muscle disease modeling and regenerative research.
-
Metformin HCl: From AMPK to Tendon Assays
2026-09-05
Metformin Hydrochloride is more than a glucose-regulating compound: it is a mechanistic probe linking cellular metabolism with tendon osteogenic differentiation. This article presents an assay-centered framework for studying AMPK, Nr4a1/Wnt/β-catenin signaling, and heterotopic ossification without overstating translational evidence.
-
Realgar, Ornithine, and Astrocyte Glycolysis
2026-09-04
The 2025 Advanced Science study identifies a liver–brain mechanism in realgar-induced CNS toxicity: hepatic OTC inhibition increases ornithine, while arsenic and ornithine converge on astrocyte ZBTB7A signaling to suppress glycolysis. Its integrated animal, cellular, transcriptomic, and metabolomic design provides a framework for studying metabolic drivers of neurotoxicity.
-
Epalrestat: Aldose Reductase Inhibitor Workflows
2026-09-04
Epalrestat provides a practical way to interrogate aldose reductase, polyol flux, and oxidative-stress responses in diabetic complication and neurodegeneration models. This workflow also shows how to extend those questions into cancer fructose-metabolism studies without overstating the current evidence.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-03
Build sensitive rabbit-primary staining workflows for immunofluorescence, IHC, ICC, and flow cytometry with a light-protected Cy3-conjugated secondary antibody. This guide connects practical assay design to a NETs toxicology study, while emphasizing controls, quantitative readouts, and troubleshooting rather than unsupported performance claims.